Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Barry JamesEVP, President, LSG |  BIOBIO.BBIO-RAD LABORATORIES, INC.Tax withholding | F | $181K 470 sh | Sep 9, 2026 |
| 22 | Asmerom AmineChief Accounting Officer |  CHYMChime Financial, Inc.Open-market sale · 10b5-1 plan | SELL | $325K 10.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 22 | Dignan AndyPresident |  FIVNFive9, Inc.Open-market sale · 10b5-1 plan | SELL | $147K 4,379 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 22 | Engelhardt Eva AnetteEVP, President, CDG | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $187K 485 sh | Sep 9, 2026 traded Sep 6, 2026 |
| 22 | Russotti GregorySee Remarks |  IPSCCentury Therapeutics, Inc.Open-market sale | SELL | $1,095 534 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 22 | Barry JamesEVP, President, LSG | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $142K 369 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 21 | Carter Philip MatthewSVP & Chief Financial Officer |  SWKSSKYWORKS SOLUTIONS, INC.Option exercise | M | — 9,917 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 21 | Cutler David GChief Technology Officer |  EYENational Vision Holdings, Inc.Option exercise | M | — 13.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 21 | Tiran AssafEVP Cross Suez & Atlantic BU |  ZIMZIM Integrated Shipping Services Ltd.Option exercise | M | — 16.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 21 | Higgins John GerardChief, Client &Partner Success |  PEGAPEGASYSTEMS INCOption exercise | M | — 2,280 sh | Sep 9, 2026 traded Sep 7, 2026 |
| 21 | Purcell Lynn SebastianDirector, 10% Owner |  CNXUConexeu Sciences Inc.In-the-money exercise | X | $500K 217.6K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 21 | Budur KumarCHIEF MEDICAL OFFICER |  HRMYHarmony Biosciences Holdings, Inc.Open-market sale | SELL | $43K 1,000 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 20 | Pfeiffer DeborahEVP & Pres, Presort Services |  PBIPITNEY BOWES INC /DE/Open-market sale · 10b5-1 plan | SELL | $342K 20.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 20 | Azamian Bobak R.Director, President/CEO and Board Chair |  TARSTarsus Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $265K 2,900 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | Wassil JimEVP, Chief Scientific Ofc, COO |  PCVXVaxcyte, Inc.Open-market sale | SELL | $79K 1,334 sh | Sep 9, 2026 traded Sep 9, 2026 |
| 20 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $974K 22.8K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | Chen Sean ChihhsiangPresident and COO |  AMBQAmbiq Micro, Inc.Open-market sale · 10b5-1 plan | SELL | $123K 2,126 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 20 | Azamian Bobak R.Director, President/CEO and Board Chair | TARSTarsus Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $641K 7,100 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | McMahon Stephen AEVP, Chief Customer Officer |  DTDynatrace, Inc.Option exercise | M | — 5,821 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Barry JamesEVP, President, LSG | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 1,027 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Akgonul Rifat KerimChief Product Officer | PEGAPEGASYSTEMS INC Option exercise | M | — 2,202 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Sluis FrankCFO |  ONONOn Holding AGOption exercise | M | — 1,684 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Scheiwer Mark JEVP, CFO & CAO |  SMGSCOTTS MIRACLE-GRO COGrant or award | A | — 47 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Yates Daniel S.SVP, Chief Accounting Officer | DTDynatrace, Inc. Option exercise | M | — 718 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Carr DouglasSVP Finance & Operations | IPSCCentury Therapeutics, Inc. Open-market sale | SELL | $521 254 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 19 | Aviles EdithDirector | SMGSCOTTS MIRACLE-GRO CO Grant or award | A | — 118 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Allison SchwartzDirector | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 228 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Yates Daniel S.SVP, Chief Accounting Officer | DTDynatrace, Inc. Option exercise | M | — 558 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Mulshine Brendan MartinCo-President and CRO |  RYANRYAN SPECIALTY HOLDINGS, INC.Derivative conversion | C | — 40.0K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Engelhardt Eva AnetteEVP, President, CDG | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 1,027 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Allison SchwartzDirector | BIOBIO.BBIO-RAD LABORATORIES, INC. Tax withholding | F | $32K 82 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Allison SchwartzDirector | BIOBIO.BBIO-RAD LABORATORIES, INC. Option exercise | M | — 92 sh | Sep 9, 2026 traded Sep 6, 2026 |
| 19 | Mulshine Brendan MartinCo-President and CRO | RYANRYAN SPECIALTY HOLDINGS, INC. Derivative conversion | C | — 40.0K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Higgins John GerardChief, Client &Partner Success | PEGAPEGASYSTEMS INC Option exercise | M | — 1,616 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 19 | Zugelder DanEVP, Chief Revenue Officer | DTDynatrace, Inc. Option exercise | M | — 3,220 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 19 | Budur KumarCHIEF MEDICAL OFFICER | HRMYHarmony Biosciences Holdings, Inc. Option exercise | M | $326K 10.8K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 18 | McMahon Stephen AEVP, Chief Customer Officer | DTDynatrace, Inc. Tax withholding | F | $112K 2,149 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 18 | McKim Scott JosephEVP, Chief Financial Officer |  BAFNBayFirst Financial Corp.Other acquisition or disposition | J | $300 48 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 18 | McMahon Stephen AEVP, Chief Customer Officer | DTDynatrace, Inc. Tax withholding | F | $163K 3,141 sh | Sep 9, 2026 traded Sep 5, 2026 |
| 18 | Oliver Robin LeighDirector, COO | BAFNBayFirst Financial Corp. Other acquisition or disposition | J | $300 48 sh | Sep 9, 2026 traded Sep 4, 2026 |
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K